Exploring the mechanism of contact-dependent cell-cell communication on chemosensitivity based on single-cell high-throughput drug screening platform
文献类型:期刊论文
作者 | Jiang, Yue6,7; Ren, Xuelian6; Liu, Guobin6; Chen, Shulei7; Hao, Ming7; Deng, Xinran7; Huang, He1,5,6; Liu, Kun2,3,4,7 |
刊名 | TALANTA
![]() |
出版日期 | 2024-06-01 |
卷号 | 273页码:8 |
关键词 | Microfluidic chip High-throughput drug screening Quantitative proteomics Contact-dependent cell-cell communication Tumour single cells |
ISSN号 | 0039-9140 |
DOI | 10.1016/j.talanta.2024.125869 |
通讯作者 | Huang, He(hhuang@simm.ac.cn) ; Liu, Kun(kliu@mail.neu.edu.cn) |
英文摘要 | High-throughput drug screening (HTDS) has significantly reduced the time and cost of new drug development. Nonetheless, contact-dependent cell-cell communication (CDCCC) may impact the chemosensitivity of tumour cells. There is a pressing need for low-cost single-cell HTDS platforms, alongside a deep comprehension of the mechanisms by which CDCCC affects drug efficacy, to fully unveil the efficacy of anticancer drugs. In this study, we develop a microfluidic chip for single-cell HTDS and evaluate the molecular mechanisms impacted by CDCCC using quantitative mass spectrometry-based proteomics. The chip achieves high-quality drug mixing and singlecell capture, with single-cell drug screening results on the chip showing consistency with those on the 96 -well plates under varying concentration gradients. Through quantitative proteomic analysis, we deduce that the absence of CDCCC in single tumour cells can enhance their chemoresistance potential, but simultaneously subject them to stronger proliferation inhibition. Additionally, pathway enrichment analysis suggests that CDCCC could impact several signalling pathways in tumour single cells that regulate vital biological processes such as tumour proliferation, adhesion, and invasion. These results offer valuable insights into the potential connection between CDCCC and the chemosensitivity of tumour cells. This research paves the way for the development of single-cell HTDC platforms and holds the promise of advancing tumour personalized treatment strategies. |
WOS关键词 | CANCER ; HETEROGENEITY ; RESISTANCE |
资助项目 | The 111 Project[B16009] ; Natural Science Foundation of Shenyang City[22-315-6-01] ; Natural Science Foundation of Shanghai[23ZR1474600] ; National Natural Science Foundation of China[22277125] ; National Natural Science Foundation of China[92253306] |
WOS研究方向 | Chemistry |
语种 | 英语 |
WOS记录号 | WOS:001208365400001 |
出版者 | ELSEVIER |
源URL | [http://119.78.100.183/handle/2S10ELR8/310995] ![]() |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Huang, He; Liu, Kun |
作者单位 | 1.647 Songtao Rd, Shanghai 200120, Peoples R China 2.3-11 WenHua Rd, Shenyang 110004, Peoples R China 3.Northeastern Univ, Minist Educ, Key Lab Data Analyt & Optimizat Smart Ind, Shenyang, Peoples R China 4.Northeastern Univ, Natl Frontiers Sci Ctr Ind Intelligence & Syst Opt, Shenyang 110819, Peoples R China 5.Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou 310024, Peoples R China 6.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Chem Biol, Shanghai 201203, Peoples R China 7.Northeastern Univ, Sch Mech Engn & Automat, Shenyang 110819, Peoples R China |
推荐引用方式 GB/T 7714 | Jiang, Yue,Ren, Xuelian,Liu, Guobin,et al. Exploring the mechanism of contact-dependent cell-cell communication on chemosensitivity based on single-cell high-throughput drug screening platform[J]. TALANTA,2024,273:8. |
APA | Jiang, Yue.,Ren, Xuelian.,Liu, Guobin.,Chen, Shulei.,Hao, Ming.,...&Liu, Kun.(2024).Exploring the mechanism of contact-dependent cell-cell communication on chemosensitivity based on single-cell high-throughput drug screening platform.TALANTA,273,8. |
MLA | Jiang, Yue,et al."Exploring the mechanism of contact-dependent cell-cell communication on chemosensitivity based on single-cell high-throughput drug screening platform".TALANTA 273(2024):8. |
入库方式: OAI收割
来源:上海药物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。